1. Feasibility and image quality of myocardial perfusion imaging by CMR in patients with conditional and non-conditional cardiac devices. (3rd October 2022) Authors: Meier, C; Bietenbeck, M; Drakos, S; Chamling, B; Vehof, V; Stalling, P; Yilmaz, A Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hybrid CMR- and FDG-PET-imaging gives new insights into the relationship of myocardial metabolic activity and fibrosis in patients with Becker muscular dystrophy. (25th November 2020) Authors: Florian, A; Vehof, V; Buether, F; Stegger, L; Yilmaz, A Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging. (3rd October 2022) Authors: Chamling, B; Bietenbeck, M; Korthals, D; Drakos, S; Vehof, V; Stalling, P; Weil, M; Meier, C; Yilmaz, A Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗